PRGO up +2.15% percent right now. $PRGO High is at 155.89

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
PRGO up +2.15% percent right now. $PRGO High is at 155.89 and the Low 152.62 with current volume of 1,927,000.

Recent News posted below.

PRGO Perrigo Company Recent Headline News

Perrigo to re-launch the expectorant tablets Guaifenesin Extended-Release 600mg in the US
M2 - Fri Nov 07, 6:22AM CST
Healthcare company Perrigo Company (NYSE RGO) said on Thursday that it has re-initiated shipments of Guaifenesin 600mg Extended-Release tablets to its retail and wholesale customers in the US.
PRGO: 155.77 (+3.28)

Perrigo to buy Omega Pharma
at Investor's Business Daily - Thu Nov 06, 5:49PM CST
The Ireland-based pharmaceuticals maker agreed to buy Belgium-based Omega Pharma for $4.5 bil, including debt, in a deal designed to expand Perrigo's (PRGO) presence in Europe. In its fiscal Q1, Perrigo earned $1.40 a share, missing views by 4 cents,...
PRGO: 155.77 (+3.28)

After Yesterday's Decline of 3.79%, Perrigo Offers Investors Better Value
Comtex SmarTrend(R) - Thu Nov 06, 3:41PM CST
Perrigo (NASDAQ RGO) traded in a range yesterday that spanned from a low of $145.41 to a high of $160.85. Yesterday, the shares fell 3.8%, which took the trading range below the 3-day low of $158.30 on volume of 4.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
PRGO: 155.77 (+3.28)

Perrigo (PRGO) Earnings Report: Q1 2015 Conference Call Transcript
at The Street - Thu Nov 06, 3:39PM CST
The following Perrigo (PRGO) conference call took place on November 6, 2014, 10:00 AM ET. This is a transcript of that earnings call:
PRGO: 155.77 (+3.28)

Perrigo Misses on Earnings and Sales, Maintains Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 10:08AM CST
Perrigo Companys reported first-quarter fiscal 2015 earnings of $1.40 per share.
AGN: 196.00 (-1.40), BIIB: 320.75 (-2.72), PRGO: 155.77 (+3.28), ABBV: 61.50 (-1.21)

Perrigo Reinitiates Shipments Of Guaifenesin Extended-Release 600mg Tablets, The Store Brand Equivalent To Mucinex® 600mg Extended-Release Tablets
PR Newswire - Thu Nov 06, 5:39AM CST
Perrigo Company plc (NYSE: PRGO; TASE) announced today that it has reinitiated shipments of Guaifenesin 600mg Extended-Release tablets to its retail and wholesale customers in the United States. The product will be packaged and marketed under store and proprietary brands and will be a high quality, value alternative to Mucinex® 600mg Extended-Release tablets.
PRGO: 155.77 (+3.28)

Perrigo Company PLC Reports Record First Quarter Revenue, Adjusted Net Income And Adjusted Margins
PR Newswire - Thu Nov 06, 5:32AM CST
-- Fiscal first quarter net sales increased to a first quarter record of $952 million.
PRGO: 155.77 (+3.28)

Perrigo Company plc To Acquire Omega Pharma NV For EUR 3.6 Billion Creating A Top Five Global OTC Company
PR Newswire - Thu Nov 06, 5:26AM CST
Perrigo Company plc (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," and Omega Pharma NV, one of the largest OTC healthcare companies in Europe, headquartered in Nazareth, Belgium, today announced that they have entered into a definitive agreement in which Perrigo has agreed to acquire Omega for EUR 3.6 billion, or $4.5 billion, comprised of the purchase of Omega's equity for EUR 2.48 billion and the assumption of EUR 1.1 billion in debt. The transaction, funded through a combination of cash, debt, and equity, will enhance Perrigo's leading OTC product offering and expand its distribution through Omega's strong established platform.
PRGO: 155.77 (+3.28)

Will Perrigo (PRGO) Disappoint This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 3:45PM CST
Perrigo (PRGO), which is scheduled to report first-quarter fiscal 2015 results on Nov 6, had delivered a positive earnings surprise of 12.26%.
MDVN: 112.77 (+7.82), ACT: 245.91 (-4.47), PRGO: 155.77 (+3.28), ALNY: 95.84 (+2.93)

Financial Results, Appointments, and Upcoming Conference Calls - Research Reports on Yelp, Vantiv, Discovery, Vistaprint and Perrigo
PR Newswire - Tue Nov 04, 7:55AM CST
Today, Analysts Review released its research reports regarding Yelp, Inc. (NYSE: YELP), Vantiv, Inc. (NYSE: VNTV), Discovery Communications, Inc. (NASDAQ: DISCA), Vistaprint N.V. (NASDAQ: VPRT) and Perrigo Company Plc (NYSE: PRGO). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7669-100free.
PRGO: 155.77 (+3.28), DISCA: 32.62 (-0.28), VPRT: 67.41 (+0.92), VNTV: 30.75 (+0.25), YELP: 58.41 (-0.37)

Perrigo Company plc Announces Quarterly Dividend
PR Newswire - Mon Nov 03, 2:12PM CST
Perrigo Company plc (NYSE: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.105 per share, payable on December 16, 2014 to shareholders of record on November 28, 2014.
PRGO: 155.77 (+3.28)

Perrigo Rises 4.08% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Oct 30, 4:18PM CDT
Perrigo (NASDAQ RGO) traded in a range yesterday that spanned from a low of $153.00 to a high of $161.35. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $156.35 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PRGO: 155.77 (+3.28)

Lannett Co. Gets Growth Rx In Generic Drugs Group
at Investor's Business Daily - Mon Oct 27, 4:59PM CDT
Generic-drug maker Lannett Co. boasts a robust pipeline and has its sights on growing revenue substantially over the next several years. The Philadelphia-based company is already on solid footing. In late August, it reported fiscal 2014...
LCI: 50.17 (-0.82), PRGO: 155.77 (+3.28), ACT: 245.91 (-4.47), AKRX: 36.59 (-1.29), TEVA: 57.70 (-1.02)

Technical Report on Pharma Stocks - Auxilium Pharma, Perrigo, Endo Intl., Depomed, and Ampio Pharma
PR Newswire - Fri Oct 24, 7:45AM CDT
Investor-Edge has initiated coverage on the following equities: Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL), Perrigo Company PLC (NYSE: PRGO), Endo International PLC (NASDAQ: ENDP), Depomed Inc. (NASDAQ: DEPO), and Ampio Pharmaceuticals Inc. (NYSE MKT: AMPE). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Thursday, October 23, 2014, the NASDAQ Composite ended at 4,452.79, up 1.60%, the Dow Jones Industrial Average advanced 1.32%, to finish the day at 16,677.90, and the S&P 500 closed at 1,950.82, up 1.23%. The gains were broad based as eight out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 744.13, up 1.75%, with the index also advancing 3.88% in the previous three trading sessions. Register for your complimentary reports on these five stocks at:
ENDP: 68.96 (-1.23), PRGO: 155.77 (+3.28), AUXL: 32.75 (-0.52), DEPO: 14.27 (-0.64), AMPE: 3.82 (+0.12)

Perrigo Company plc To Release First Quarter Fiscal Year 2015 Results On November 6, 2014
PR Newswire - Thu Oct 23, 7:34AM CDT
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will release financial results for its first quarter fiscal year 2015 on Thursday, November 6, 2014 at approximately 8:00 a.m. (ET). The Company will conduct a conference call at 10:00 a.m. (ET) hosted by Joseph C. Papa, Perrigo's Chairman, President and Chief Executive Officer.
PRGO: 155.77 (+3.28)

SmarTrend Watching for Potential Pullback in Shares of Perrigo After 1.85% Gain
Comtex SmarTrend(R) - Mon Oct 20, 5:16PM CDT
Perrigo (NASDAQ RGO) traded in a range yesterday that spanned from a low of $146.39 to a high of $149.63. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $148.68 on volume of 964,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PRGO: 155.77 (+3.28)

Perrigo CEO Constructs "Five Pillars" For Success
at Investor's Business Daily - Fri Oct 17, 4:03PM CDT
Trained as a pharmacist, Joseph Papa learned to scrutinize science when making a decision. Earning his bachelor's degree in pharmacy taught him to use Socratic questions to dig for answers. "The pharmaceuticals business comes down to what are you...
PRGO: 155.77 (+3.28), GILD: 106.45 (-0.49)

Perrigo Animal Health's Kansas manufacturing facility earns SQF Certification
M2 - Wed Oct 15, 6:57AM CDT
Perrigo Animal Health, a division of Perrigo Company (NYSE RGO)(NYSE:TASE) revealed on Tuesday that its Kansas manufacturing facility has successfully passed the Safety Quality Food (SQF) Code Edition 7.1, Level 2 Certification under the Global Food Safety Initiative (GFSI).
PRGO: 155.77 (+3.28)

ScinoPharm Recognized as API Supplier of the Year at Global Generics & Biosimilars Awards
PR Newswire - Wed Oct 15, 1:32AM CDT
ScinoPharm (TWSE:1789) announced that it was named the "Active Pharmaceutical Ingredient (API) Supplier of the Year" at the Global Generics and Biosimilars Awards co-hosted by Generics bulletin and Ark Patent Intelligence. The award recognizes excellent performance across a range of business activities and was won in strong competition against a number of leading Pharmaceutical companies including Dr. Reddy's, Teva, Perrigo, Unichem, etc.
PRGO: 155.77 (+3.28)

Perrigo Animal Health Receives SQF Certification
PR Newswire - Tue Oct 14, 9:25AM CDT
Perrigo Animal Health, a division of Perrigo Company plc (NYSE: PRGO; TASE), is proud to announce that its Kansas City, Kansas, manufacturing facility has obtained Safety Quality Food (SQF) Code Edition 7.1, Level 2 Certification. The SQF registration covers the production of all pet treats manufactured in the Kansas-based plant.
PRGO: 155.77 (+3.28)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 607

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 445

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 303

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
AutoShop Answers Extends 2027 Training Into Fridays

Updated Category News Views 60

A repair bay can hum all day while the back office quietly bleeds profit. That unglamorous reality is why AutoShop Answers adding nine Friday specialty classes to its 2027 Key2Key Weekend calendar deserves a closer look. This is not a new tool chest or some vague motivational roadshow; it is an attempt to give independent shop owners an extra day to work on the pieces...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 731

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 385

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
EyePoint Lawsuit Puts DURAVYU Claims Under a Microscope

Updated Category News Views 50

Nothing makes biotech investors reach for the aspirin faster than a lawsuit centered on whether a drug worked as advertised. EyePoint, Inc. is facing a proposed federal securities class action alleging that the company overstated the effectiveness of DURAVYU and, by extension, its clinical, regulatory, and commercial prospects. That is a serious allegation, but it remains...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading

Top 5 Most Recently Viewed Articles

Northern Trust Adjusts Prime Rate to Enhance Financial Services

Updated Category News Views 90

Northern Trust Lowers Its Prime Rate Northern Trust has made an important change by reducing its prime rate from 8.50% to 8.00%. This adjustment takes effect immediately and demonstrates the company's commitment to offering competitive financial solutions. The Impact of Changes in the Prime Rate The prime rate serves as the benchmark interest rate that banks provide to...

Continue Reading
Experiencing Luxury with CÎROC at TGL's Prime Events

Updated Category News Views 225

Exciting Partnership Announced for TGL Events TGL, a premier team golf league, has named CÎROC Ultra-Premium Vodka as its Official Vodka Partner. This collaboration marks a new era of luxury, promising a unique experience for fans and attendees at TGL events. The partnership aims to elevate the leisure experience that TGL provides, integrating elegance and sophistication...

Continue Reading
Global Wellness Institute Introduces Groundbreaking Podcast

Updated Category News Views 413

Global Wellness Institute Unveils Innovative Podcast The Global Wellness Institute (GWI) has launched an exciting new podcast titled The Wellness Roundtable: Longevity. This podcast aims to delve into the intricate science and strategies behind improving longevity and healthspan. Bringing forth expert insights, this series shifts the narrative from abstract theories to...

Continue Reading
Kennedy-Wilson Welcomes New Leaders to Its Board for Growth

Updated Category News Views 106

Kennedy-Wilson Welcomes New Leaders to Its Board Kennedy-Wilson Holdings, Inc. (NYSE: KW), a global real estate investment company, has made noteworthy strides by appointing two new independent directors to its Board. This strategic decision is indicative of the company’s aim to reinforce its governance during a pivotal time in the real estate market. Introducing the...

Continue Reading
MoxiWorks Transforms Strategy with MoxiBalance's Sale to Upfront

Updated Category News Views 285

MoxiWorks Sells MoxiBalance to Upfront for Strategic Growth The recent sale of MoxiBalance by MoxiWorks represents a significant strategic shift, allowing the company to prioritize its core mission of empowering real estate agents. The transition will enable MoxiWorks to concentrate on enhancing sales and marketing solutions while providing Upfront, known for its...

Continue Reading